Foley Serves as IP Counsel to NantKwest in Record-Breaking Biotech IPO
11 August 2015
Foley helped NantKwest, Inc. (formerly known as Conkwest, Inc.) make history last week with an initial public offering (IPO) valuing the company at $2.6 billion, the highest ever IPO for a biotech company with no approved drugs.
Foley served as intellectual property counsel on the transaction and played a critical role in helping NantKwest develop a strong IP strategy and portfolio. Foley prepared more than 30 patent applications in advance of the client’s successful acquisition and IPO. The Foley team was led by Paul Stewart, Marc Morley, Simon Elliott, Jerry Swiss and Kristel Schorr.
People
Related News
01 May 2024
Press Releases
Foley Continues to Grow Its East Coast Transactions Practice, Adds M&A Partner Jeff Symons in New York
Foley & Lardner LLP announced today that it has strengthened its Transactions Practice with the addition of M&A partner Jeff Symons in New York.
30 April 2024
Press Releases
Foley Ventures Announces Fifth Fund to Invest in Firm Clients
Foley Ventures is pleased to announce Foley Ventures V, its latest venture fund launched in April 2024 to invest in companies and debt and equity fund clients.
24 April 2024
Press Releases
Nathaniel Lacktman Joins Tampa Bay Wave’s HealthTech|X Accelerator Advisory Council
Foley & Lardner LLP partner Nathaniel “Nate” Lacktman will serve as a member of the Advisory Council for Tampa Bay Wave’s inaugural HealthTech|X Accelerator program, an innovative initiative to support high-potential health technology startups ready to scale in Tampa and beyond.